Healthcare,Healthcare sector projects by GlaxoSmithKline Pharmaceuticals Ltd. in
Project Information
5433
GlaxoSmithKline Pharmaceuticals Ltd.
Global Pharmaceutical Major Glaxosmithkline Will Invest Rs 864 Crore In India To Set Up A Medicine Manufacturing Unit. The Location Of The New Facility Is Yet To Be Finalised, But The Lead Site Is In Bangalore. The Facility, Expected To Be Operational By 2017, Will Include A Warehouse, Site Infrastructure And Utilities To Support The Manufacturing And Packing Of Medicines. Glaxosmithkline Plc (GSK) Is A British Multinational Pharmaceutical, Biologics, Vaccines And Consumer Healthcare Company.
Project Value
INR 864 Crore /-
Conceptual Stage
Not Specified
India
Healthcare,Healthcare
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
